AJANTPHARM price chart
Daily close · 5-year history
Instrument details
Identifiers & classification
- Symbol
- AJANTPHARM
- MB Code
- MBEQU5444
- ISIN
- INE031B01049
- BSE code
- 532331
- Industry group
- Pharmaceuticals & Biotechnology
- Screener
- View peers →
Latest earnings
Most recent declared quarter
- Quarter
- Mar 2026
- Revenue
- 1421.64 Cr
- Net profit
- 266.7 Cr
- EPS
- 21.34
- YoY revenue
- +21.47%
Company documents
12 PDFs across 4 categories
Audited annual reports & financial statements
Earnings call transcripts & Q&A
Investor decks & strategy updates
Exchange filings & corporate announcements
Corporate timeline
Earnings, news & corporate actions for AJANTPHARM
Ajanta Pharma touched a record high after strong Q1 results and announced a 1,250% dividend payout, signaling robust performance and shar…
EPS 21.35 vs est. 21.27
Beat estimates by 0.39%
Ajanta Pharma reported Q4 net profit of ₹266.7 crore, up 18.4% YoY, on 21.5% revenue growth to ₹1,421.6 crore. FY26 profit rose 15% to ₹1…
EPS 21.91 vs est. 20.33
Beat estimates by 7.76%
Ajanta Pharma reported a 17.6% rise in net profit to ₹274 crore and a 20% revenue increase to ₹1,375 crore for Q3 FY2026, driven by stron…
Ajanta Pharma shares rose 13% over three months, with Motilal Oswal projecting a 16% upside and a target price of Rs 3,145. The company i…
Ajanta Pharma, in partnership with Biocon, aims to tap into the growing weight-loss drug market, targeting a potential $100 billion marke…
Dividend of ₹28.00 per share
Ex-date corporate action
Price returns
Historical performance
Technicals
Indicator consensus